Medicina
Departamento
Yokohama City University Medical Center
Yokohama, JapónPublicaciones en colaboración con investigadores/as de Yokohama City University Medical Center (9)
2023
-
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
The Lancet, Vol. 402, Núm. 10415, pp. 1835-1847
-
Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention (Nature Reviews Cardiology, (2022), 19, 10, (684-703), 10.1038/s41569-022-00687-9)
Nature Reviews Cardiology
-
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
European Urology
-
Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
European Journal of Cancer
2022
-
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
Scientific Data, Vol. 9, Núm. 1
-
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703
2019
-
An international perspective on hospitalized patients with viral community-acquired pneumonia
European Journal of Internal Medicine, Vol. 60, pp. 54-70
-
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Journal of Infection, Vol. 79, Núm. 4, pp. 300-311
2018
-
Microbiological testing of adults hospitalised with community-acquired pneumonia: An international study
ERJ Open Research, Vol. 4, Núm. 4